NASDAQ:ADIL | Buybacks | ADIAL PHARMACEUTICALS, INC.

ADIL Buybacks

1 quarter-specific issuer repurchase-cash observations normalized from SEC filings, newest first. A filed zero remains visible; a missing filing fact is never converted into zero. This page shows rows 1–1; provenance stays internal.

Issuer profilePeriod endTypeReported cash
ADIAL PHARMACEUTICALS, INC.2023-12-31Reported repurchase cash$0.00